Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $847.13 | 43 | 96.9% |
| Education | $27.27 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $234.92 | 12 | $0 (2023) |
| Indivior Inc. | $160.39 | 8 | $0 (2023) |
| Lundbeck LLC | $100.92 | 5 | $0 (2023) |
| ITI, Inc. | $86.10 | 4 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $75.86 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $64.90 | 3 | $0 (2023) |
| Alkermes, Inc. | $61.00 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $43.05 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $19.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.27 | 1 | E.R. Squibb & Sons, L.L.C. ($27.27) |
| 2023 | $299.75 | 15 | Lundbeck LLC ($70.61) |
| 2022 | $481.66 | 25 | ABBVIE INC. ($143.76) |
| 2021 | $65.72 | 3 | AbbVie Inc. ($24.30) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/01/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: OUD | ||||||
| 07/13/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: PSYCHIATRY | ||||||
| 07/13/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: CNS | ||||||
| 06/15/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: PSYCHIATRY | ||||||
| 06/08/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Neuropsychiatry | ||||||
| 06/06/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: PSYCHIATRY | ||||||
| 03/23/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Neuropsychiatry | ||||||
| 03/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Central Nervous System | ||||||
| 02/16/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neuroscience | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Neuroscience | ||||||
| 12/09/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: BH | ||||||
| 11/07/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: BH | ||||||
| 10/13/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: BH | ||||||
| 09/20/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/07/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: BH | ||||||
| 09/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: BH | ||||||
| 08/11/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: CNS | ||||||
| 08/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 32 | 62 | $16,988 | $3,045 |
| 2022 | 2 | 35 | 84 | $23,016 | $4,974 |
| 2021 | 1 | 18 | 72 | $19,728 | $5,035 |
| 2020 | 2 | 43 | 117 | $32,058 | $8,112 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 34 | $9,316 | $1,562 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 28 | $7,672 | $1,483 | 19.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 21 | 57 | $15,618 | $2,924 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 27 | $7,398 | $2,050 | 27.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 72 | $19,728 | $5,035 | 25.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 80 | $21,920 | $5,858 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 37 | $10,138 | $2,254 | 22.2% |
About Jeffrey Sims, PMHNP-BC
Jeffrey Sims, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1104206796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeffrey Sims, PMHNP-BC has received a total of $874.40 in payments from pharmaceutical and medical device companies, with $27.27 received in 2024. These payments were reported across 44 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($847.13).
As a Medicare-enrolled provider, Sims has provided services to 128 Medicare beneficiaries, totaling 335 services with total Medicare billing of $21,166. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Cleveland, OH
- Active Since 06/09/2015
- Last Updated 06/09/2015
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104206796
Products in Payments
- VRAYLAR (Drug) $234.92
- PERSERIS (Drug) $123.21
- CAPLYTA (Drug) $86.10
- LATUDA (Drug) $75.86
- INVEGA SUSTENNA (Drug) $64.90
- ABILIFY MAINTENA (Drug) $55.26
- REXULTI (Drug) $45.66
- ARISTADA (Drug) $43.75
- INGREZZA (Drug) $43.05
- SUBLOCADE (Drug) $37.18
- COBENFY (Drug) $27.27
- AUSTEDO (Drug) $19.99
- LYBALVI (Drug) $17.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Cleveland
Lawanda Glass, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $5,787
David Kwon, Np, NP
Psychiatric/Mental Health — Payments: $4,046
Sandra Jones, Cnp, CNP
Psychiatric/Mental Health — Payments: $3,820
George Mcbride, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,722
Lindsay Conger
Psychiatric/Mental Health — Payments: $2,867
Julie Mcbride, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,834